DE69942161D1 - Genetische Adjuvanz-Impfstoffe - Google Patents

Genetische Adjuvanz-Impfstoffe

Info

Publication number
DE69942161D1
DE69942161D1 DE69942161T DE69942161T DE69942161D1 DE 69942161 D1 DE69942161 D1 DE 69942161D1 DE 69942161 T DE69942161 T DE 69942161T DE 69942161 T DE69942161 T DE 69942161T DE 69942161 D1 DE69942161 D1 DE 69942161D1
Authority
DE
Germany
Prior art keywords
genetic adjuvant
adjuvant vaccines
vaccines
genetic
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69942161T
Other languages
English (en)
Inventor
Joel R Haynes
Georg Widera
James T Fuller
Timothy Shipley
Deborah Fuller
Mary Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Priority claimed from EP99956885A external-priority patent/EP1227840B1/de
Application granted granted Critical
Publication of DE69942161D1 publication Critical patent/DE69942161D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69942161T 1999-11-03 1999-11-03 Genetische Adjuvanz-Impfstoffe Expired - Lifetime DE69942161D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07015414A EP1913957B1 (de) 1999-11-03 1999-11-03 Genetische Adjuvanz-Impfstoffe
EP99956885A EP1227840B1 (de) 1999-11-03 1999-11-03 Genetische impstoffe mit adjuvans

Publications (1)

Publication Number Publication Date
DE69942161D1 true DE69942161D1 (de) 2010-04-29

Family

ID=38763704

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69942161T Expired - Lifetime DE69942161D1 (de) 1999-11-03 1999-11-03 Genetische Adjuvanz-Impfstoffe

Country Status (5)

Country Link
EP (1) EP1913957B1 (de)
AT (1) ATE460945T1 (de)
DE (1) DE69942161D1 (de)
DK (1) DK1913957T3 (de)
SI (1) SI1227840T1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112569348B (zh) * 2019-09-29 2023-02-28 中国食品药品检定研究院 一种带状疱疹疫苗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2501743C (en) * 1994-01-21 2008-11-18 Powderject Vaccines, Inc. Gas driven gene delivery instrument
WO1998046263A1 (en) * 1997-04-14 1998-10-22 University Of Massachusetts Medical Center Saponin adjuvants in combination with dna vaccination
WO1999027961A1 (en) * 1997-12-02 1999-06-10 Powderject Vaccines, Inc. Transdermal delivery of particulate vaccine compositions
GB9818627D0 (en) * 1998-08-26 1998-10-21 Glaxo Group Ltd Improvements in dva vaccination
ES2340617T3 (es) * 1999-11-03 2010-06-07 Powderject Vaccines, Inc. Vacunas geneticas con adyuvantes.

Also Published As

Publication number Publication date
SI1227840T1 (sl) 2008-02-29
ATE460945T1 (de) 2010-04-15
DK1913957T3 (da) 2010-05-10
EP1913957B1 (de) 2010-03-17
EP1913957A1 (de) 2008-04-23

Similar Documents

Publication Publication Date Title
DK1459766T3 (da) Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
DE69929444D1 (de) Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
WO2003080114A3 (en) Imidazoquinoline adjuvants for vaccines
ATE406912T1 (de) Immunisierung gegen chlamydia tracheomatis
DK1047784T3 (da) Neissera meningitidis-antigener
DK1385876T3 (da) Gonococcusproteiner og nukleinsyrer
WO2003059381A3 (en) Immunogenic preparations and vaccines on the basis of mrna
CY1112749T1 (el) Εμβολια διεγερσης/αναμνησης κατα της ελονοσιας
DK1147117T3 (da) Immunologiske adjuvansforbindelser
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
DE60144201D1 (de) Lawsonia intracellularis Impfstoff
WO2004098526A3 (en) Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
DE69828182D1 (de) Polynukleotid-impfstoff-formulierungen
CY1107845T1 (el) Γενετικα εμβολια με ανοσοενισχυτικο
DK1913957T3 (da) Genetiske adjuvant-vacciner
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
NO20041564L (no) Infeksios lakse anemi-virus vaksine
DK1490100T3 (da) Kombinerede DNA/proteinvaccinepræparater
ATE251215T1 (de) Helicobacter felis impfstoff

Legal Events

Date Code Title Description
8364 No opposition during term of opposition